James Engelhart
Director/Board Member bei Our Lady of Mercy Academy
Profil
Herr James Engelhart, CPA, ist Chief Financial Officer & Treasurer bei Biohaven Pharmaceutical Holding Co. Ltd. Er ist Mitglied des Verwaltungsrats der Our Lady of Mercy Academy. Herr Engelhart war zuvor als Executive Director-Finance bei Alexion Pharmaceuticals, Inc. beschäftigt, als Finance Director bei Energizer SpinCo, Inc. und als Auditor bei Coopers & Lybrand LLP. Er erhielt seinen Bachelor-Abschluss von der Villanova University und einen Bachelor-Abschluss von der Villanova School of Business.
Aktive Positionen von James Engelhart
| Unternehmen | Position | Beginn |
|---|---|---|
| Our Lady of Mercy Academy | Director/Board Member | - |
Ehemalige bekannte Positionen von James Engelhart
| Unternehmen | Position | Ende |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Director of Finance/CFO | 15.12.2021 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.05.2016 |
| ENERGIZER HOLDINGS, INC. | Corporate Officer/Principal | 01.07.2014 |
| Coopers & Lybrand LLP | Corporate Officer/Principal | 01.01.1991 |
Ausbildung von James Engelhart
| Villanova School of Business | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ENERGIZER HOLDINGS, INC. | Consumer Non-Durables |
| Private Unternehmen | 4 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
| Coopers & Lybrand LLP | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
| Our Lady of Mercy Academy |
